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The physiological function of the immune system and the response to therapeutic
immunomodulators may be sensitive to combinatorial cytokine micro-environments that
shape the responses of specific immune cells. Previous work shows that paracrine
cytokines released by virus-infected human dendritic cells (DC) can dictate the matura-
tion state of naïve DCs.To understand the effects of paracrine signaling, we systematically
studied the effects of combinations cytokines in this complex mixture in generating an anti-
viral state. After naïve DCs were exposed to either IFNβ or to paracrine signaling released
by DCs infected by Newcastle disease virus (NDV), microarray analysis revealed a large
number of genes that were differently regulated by the DC-secreted paracrine signaling.
In order to identify the cytokine mechanisms involved, we identified 20 cytokines secreted
by NDV infected DCs for which the corresponding receptor gene is expressed in naïve
DCs. By exposing cells to all combinations of 19 cytokines (leave-one-out studies), we
identified five cytokines (IFNβ,TNFα, IL-1β,TNFSF15, and IL28) as candidates for regulating
DC maturation markers. Subsequent experiments identified IFNβ, TNFα, and IL1β as the
major contributors to this anti-viral state. This finding was supported by infection studies
in vitro, by T-cell activation studies and by in vivo infection studies in mouse. Combina-
tion of cytokines can cause response states in DCs that differ from those achieved by the
individual cytokines alone.These results suggest that the cytokine microenvironment may
act via a combinatorial code to direct the response state of specific immune cells. Further
elucidation of this code may provide insight into responses to infection and neoplasia as
well as guide the development of combinatorial cytokine immunomodulation for infectious,
autoimmune, and immunosurveillance-related diseases.
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INTRODUCTION
The limitations of single cytokine therapy have motivated interest
in evaluating the effects of combinatorial treatment. Individual
therapeutic cytokines often fail to achieve full or sustained clin-
ical benefits for many patients. For example, IFNα, which is the
current therapy for chronic hepatitis C infection, fails to clear
HCV titers in half of treated patients (1). The cytokine inter-
feron beta (IFNβ) has limited activity against multiple sclerosis
in a large segment of patients (2). Cytokine combination therapy,
where two or more cytokine-based medications are simultane-
ous administered to treat a single disease, has shown promise in
multiple medical conditions, such as cancer (3), myocardial infarc-
tion (4), and osteoporosis (5). Recent studies have also begun
to reveal how combined extracellular stimuli can synergistically
direct the responses of immune cells. Retinoic acid combined with
IL-15 causes dendritic cells (DCs) to skew the T-cell polarization
toward TH17 cells (6). SCF and IL-2 have a synergistic effect on
the proliferation NK cells (7). TNFα and IFNγ act together on
smooth airway cells to enhance CXCL-10 expression (8). IL17
together with TNFα or IL1β induces MCP-1 and MIP-2 in murine
mesangial cells (9). Despite its potential, studying combinations of
cytokines is experimentally difficult and relatively little systematic
exploration in this important area has been reported.
We previously reported that paracrine signaling mediated by
the complex mixture of cytokines secreted by virus-infected DCs
in culture causes naïve uninfected DCs to develop an anti-viral
state characterized by upregulation of DC maturation markers,
increased phagocytic activity, and greater resistance to viral infec-
tion (10). Since the discovery of type I interferon, paracrine
cytokine signaling has been recognized as a crucial component
in orchestrating the immune responses to virus infection. How-
ever, IFNβ pretreatment alone is not sufficient to induce this
paracrine induction of anti-viral activated DCs (10). In the present
study, we investigate the combinatorial cytokine code underlying
this effect, by studying combinations of the single components
of the secretome of virus-infected DCs. Understanding how this
combinatorial cytokine code modulates immune responses may
guide the development of better combination therapy approaches
and help elucidate how the microenvironment directs appropriate
responses in specific cell types during infection.
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MATERIALS AND METHODS
DIFFERENTIATION OF DCs
All human research protocols for this work have been reviewed
and approved by the IRB of the Mount Sinai School of Medi-
cine. Monocyte-derived DCs were obtained from healthy human
blood donors following a standard protocol described elsewhere
(11). Briefly, human peripheral blood mononuclear cells were iso-
lated from buffy coats by Ficoll density gradient centrifugation
(Histopaque, Sigma Aldrich) at 1450 rpm and CD14+ monocytes
were immunomagnetically purified by using a MACS CD14 iso-
lation kit (Miltenyi Biotech). Monocytes were then differentiated
into naïve DCs by 5–6 days incubation at 37°C and 5% CO2 in
DC growth media, which contains RPMI Medium 1640 (Invitro-
gen/Gibco) supplemented with 10% fetal calf serum (Hyclone),
2 mM of l-glutamine, 100 U/mL penicillin and 100 g/mL strep-
tomycin (Pen/Strep) (Invitrogen), 500 U/mL hGM-CSF (Prepro-
tech), and 1000 U/mL hIL-4 (Preprotech). All experiments were
replicated using cells obtained from different donors. Overall, we
used DCs from 21 different donors for this study.
VIRUS PREPARATION AND VIRAL INFECTION
The Newcastle disease virus (NDV) (rNDV/B1) was gener-
ated in Prof. Peter Palese’s laboratory (12). NDV-RFP, Influenza
A/California/04/09 (H1N1), and A/Puerto Rico/8/1934 (H1N1)
were obtained from Prof. Adolfo Garcia-Sastre’s laboratory (13).
For infection, virus stocks were diluted in serum free medium and
added directly onto pelleted DCs at a multiplicity of infection of 1.
GENERATION OF AVDCs
Anti-viral activated dendritic cells (AVDCs) were generated by
employing a trans-well system. The trans-well system consists
of an upper and a lower chamber separated by a 0.4µm PET
membrane (Millipore) that allows diffusion of cytokines and
chemokines through the membrane but avoids the interaction
of the cells in both chambers. To generate the AVDCs, naïve DCs
were infected as described above. After the 40 min incubation, the
cells were washed with PBS, and cultured in the trans-well system.
Infected and non-infected DCs were allocated in the upper and
lower chamber, respectively. Two independent wells were set-up
with infected or naïve non-infected DCs as positive and negative
controls. The cultures were incubated at 37°C in 5% CO2 for 18 h.
All cells were then washed in PBS and harvested for flow cytometry
analysis and RNA isolation. The supernatant was kept at −80°C
for ELISA analysis of cytokines/chemokines.
MICROARRAY ANALYSIS
Samples from AVDCs, DCs infected with NDV, and DCs treated
with IFNβ for 8 h were used for microarray analysis. Naive DCs
served as negative control. Three samples were taken per treat-
ment. RNA was extracted with the RNeasy plus kit (Qiagen) fol-
lowing the manufacturer’s protocol. Gene expression was assayed
using broad human genome specific HG-U133_Plus_2 GeneChip
expression probe arrays (Affymetrix). Raw data was processed with
the Partek Pro software using the RMA background correction,
with an adjustment of GC content as pre-background adjustment.
Data was normalized to its quantile, data was log transformed to a
base of two, and probe sets were summarized to its mean. Principal
component analysis (PCA) of samples plotted in genespace was
performed for all probe sets. Robustness of the PCA was tested
by randomization (Figure S1 in Supplementary Material). One-
way ANOVA was calculated by using Method of Moments (14).
Fisher’s least significant difference with FDR as multiple testing
correction was used to calculate the following contrasts AVDC vs.
IFNβ, AVDC vs. CTRL, IFNβ vs. CTRL, NDV vs. CTRL. List were
generated by a fold change and p-value (FDR adjusted) criteria.
Bioinformatic analysis was performed using Ingenuity software.
The data used are deposited in NCBI’s gene expression omnibus
(15) and are accessible through GEO series accession number
GSE52081 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=
GSE52081).
ELISA
In order to minimize the supernatant volume to assay, a Beadlyte
Human Multiplex ELISA analysis (Millipore) was used follow-
ing manufacturer instructions. Briefly, 100µl from each com-
partment/well was incubated in a 96-well filter PVDF 1.2µm
plate specially designed to retain cytokines/chemokines, with
a mixture of anti-cytokine IgG conjugated beads for the dif-
ferent cytokines/chemokines assayed. After 2 h incubation, the
plate was filtered and washed three times with Assay solution
(PBS pH 7.4 containing 1% BSA, 0.05% Tween-20, and 0.05%
sodium azide). The washes were followed by 1.5 h incubation with
biotin-conjugated anti-cytokine IgG. After Assay solution wash-
ing, Streptavidin–Phycoerythrin, was added followed by addition
after 30 min Stop solution [0.2% (v/v) formaldehyde in PBS pH
7.4]. The plate was then filtered and each well resuspended in
125µl of Assay buffer, and read in a Luminex 100 machine.
Single cytokine ELISA (IFNβ) was also performed according to
manufacturers protocol (PBL).
CYTOKINE TREATMENTS
Dendritic cells were exposed to 1.3µg/mL TNFα (Symansis),
9µg/mL CCL3 (Symansis), 3.8µg/mL IL8 (Symansis), 20µg/mL
CXCL10 (Peprotech), 0.5µg/mL CCL5 (Peprotech), 9µg/mL
IL6 (Peprotech), 2.8µg/mL IFNα2 (PBL InterferonSource),
0.03µg/mL CXCL12 (Peprotech), 2µg/mL IFNALPHA16 (PBL
InterferonSource), 0.03µg/mL IL12a (Symansis), 4.4µg/mL IL18
(R&D SYSTEMS), 0.2µg/mL IL1a (R&D SYSTEMS), 1µg/mL
IL1RA (R&D SYSTEMS), 4µg/mL IL28a (AbD Serotec), 4µg/mL
IL29 (R&D SYSTEMS), 0.1µg/mL TNFSF15 (AbD Serotec),
0.1µg/mL TNFSF4 (R&D Systems), 0.1µg/mL TNFSF10 (R&D
Systems), 0.2µg/mL IL1β (eBiosciences), and 8.89µg/mL IFNβ
(PBL InterferonSource) in various combinations for 8 h. For the
first screening with 20 cytokines, we used cells from three differ-
ent donors. To adjust for overall differences between individuals,
we normalized data of each individual to the median of all treat-
ments. All other cytokine screening experiments were carried out
with replicated from the same donor and then repeated with at
least two additional donors.
FLOW CYTOMETRY ANALYSIS
Cells were washed with FACS staining buffer (Beckman Coul-
ter) and stained with monoclonal antibodies for HLA-DR and
CD86 (BD Biosciences). NDV-GFP cells were analyzed without
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any additional staining. Cells were assayed on an LSRII flow
cytometer (BD Biosciences) and analyzed with Cytobank soft-
ware (16). Raw data as well as analyses can be downloaded at:
https://www.cytobank.org/cytobank/experiments?project=565
IMAGING FLOW CYTOMETRY ANALYSIS OF BEAD UPTAKE AND
APOPTOSIS
For analysis for apotosis and infectivity cells were fixed after
treatment with 1% paraformaldehyde (Electron Microscopy Sci-
ence), permeabilized with Methanol (Sigma), and washed in PBS
and stained with influenza NP specific antibodies (Abcam) and
Hoechst 33342 (Invitrogen) as nuclear dye. Single cell images were
acquired using the IS 100 Imaging flow cytometer (Amnis). Apop-
totic cells were identified by fragmentation of nucleus (intensity
of nuclear image at a 30% threshold) and shape of the bright-
field image (contrast) using IDEAS software (Amnis). To detect
phagocytosis, 1µm 488 nm fluorescence labeled latex micros-
pheres (Polysciences Corp.) at a concentration of 50 beads per
cell were co-cultured for 2 h at 37°C with cytokine pretreated cells.
Single cell images were acquired using extended depth field imag-
ing distortion in order to identify beads in different focal planes
within a cell. The numbers of beads incorporated by cells were
quantified in the images captured using image analysis software
(IDEAS Software, Amnis Corp).
REAL-TIME PCR
mRNA expression levels were quantified by real-time reverse tran-
scriptase polymerase chain reaction (PCR). RNA was isolated from
cells using Qiagen Micro RNeasy kit following the manufactures
protocol (QIAGEN). cDNA was synthesized from total RNA with
AffinityScript™ Multi-Temp RT (Stratagene) with oligo dT18 as
primer. For real-time PCR PlatinumTaq DNA polymerase (Invit-
rogen) and a SYBR green (Molecular Probes) containing buffer
were used. The real-time PCRs were performed using a thermo-
cycler (ABI7900HT; Applied Biosystems) as previously described
(21). The RNA levels for the house keeping genes ribosomal pro-
tein S11, tubulin, and β-actin were also assayed in all samples to
be used as an internal controls. mRNA measurements were nor-
malized using a robust global normalization algorithm. All control
crossing threshold (Ct) values were corrected by the median dif-
ference in all samples from Actb. All samples were then normalized
by the difference from the median Ct of the three corrected control
gene Ct levels in each sample, with the value converted to a nomi-
nal copy number per cell by assuming 2500 Actb mRNA molecules
per cell and an amplification efficiency of 93% for all reactions.
PCR results from DCs exposed to combinations of cytokines were
normalized to values from untreated cells and log 2 transformed
prior further statistical analysis. To get a picture of overall induc-
tion of those genes assayed, we summarized the log transformed
expression levels on the most right column of Figure 7. Primers
for genes can be found in the Table S3 in Supplementary Material.
T-CELL ACTIVATION ASSAY
PBMCs were exposed to inactivated native measles virus for 4 days.
From these samples, CD3 cells were isolated by negative selec-
tion using the Pan T-Cell Isolation Kit II (Miltenyi) and stained
with CFSE (Invitrogen). Those cells were then co-cultured with
cytokine pretreated DCs which were also pulsed with inactivated
native measles virus. T-cell proliferation was measured by the
reduction of CFSE intensity of cells.
IN VIVO EXPERIMENTATION
Animal studies were performed in compliance with the U.S.
Department of Health and Human Services Guide for the Care
and Use of Laboratory Animals and protocols were approved by
the Institutional Animal Care and Use Committee (IACUC) of
the Mount Sinai School of Medicine. Animals were pretreated
with murine 3.5 mg/kg BW IFNβ (PBL InterferonSource), murine
1.3 mg/kg BW TNFα (Peprotech), and 0.5 mg/kg IL1β (Peprotech)
6 and 3 h prior infection with the influenza A strain PR8 in an
inhalation chamber.
STATISTICAL ANALYSIS
Micro array analysis was performed with the Partek Pro software
1-way ANOVA was calculated by using Method of Moments (14).
Genes were compared by asymptotic unpaired t -test comparisons
followed by a Benjamini–Hochberg multiple testing correction.
All other data was analyzed with R. Maturation marker expression,
apoptosis induction, and infectivity levels were first analyzed with
ANOVA, followed with pairwise comparisons using the Tukey’s
“Honest Significant Difference” method. PCR of the gene expres-
sion after combinatorial treatment was also analyzed with ANOVA
followed Tukey’s “Honest Significant Difference” method and an
additional Bonferroni multiple testing correction for the sum-
marized data. Bead uptake data were analyzed with a pairwise
Wilcoxon Rank Sum Test with the Bonferroni method for multiple
testing correction. Survival of mice was analyzed with a Mantel–
Haenszel test for survival analysis. Data as well as the R analysis
can de downloaded from the supplementary data.
RESULTS
EXPOSURE TO PARACRINE SIGNALING FROM INFECTED DCs INDUCES
GENE EXPRESSION PROFILE DISTINCT FROM THAT CAUSED BY IFNβ
ALONE
The effects of paracrine signaling from infected DCs on naive
DCs, transforming them to what we have previously referred to
as anti-viral activated DCs [AVDC, Ref. (6)], were studied using
microarrays (Figure 1). To compare the effects of paracrine sig-
naling to the effects of a single cytokine treatment, we exposed
naive DCs either to paracrine signaling from NDV infected cells
(which generates AVDCs) or to IFNβ at a concentration found in
the supernatants of NDV infected DCs. RNA samples from naive
cells (CTRL) and NDV infected cells (NDV) were also assayed.
A PCA on the samples was performed in order to test how much
individual samples are similar to the biological replicates within a
group and how the different groups relate to each other. The PCA
showed that cells exposed to paracrine signaling from infected
DCs had a different overall expression profile than cells exposed
to IFNβ alone (Figure 1A). Top genes for vectors were CXCL11,
ISG20, ISG20, IDO1, IFI27, IFITM1, IFIT2, OASL, and CXCL9 for
principal component (PC) 1; IFIT2, CXCL11, CCDC88A, NEXN,
MALAT1, TNFSF10, P2RY12, SAMD9L, SMCHD1, and NEXN for
PC2 PPBP, MMP1, ADAM12, IRG1, AKAP12, SLC28A3, DNAJC6,
FABP4, ITGA9, and FABP4 for PC3. ANOVA (FDR p< 0.05) and
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FIGURE 1 | Paracrine signaling from virus-infected DCs cells induce a
different gene expression pattern compared to cells exposed to IFNβ
alone. Microarray profiles were obtained from human monocyte-derived DCs
exposed to paracrine signaling from NDV infected DCs or to IFNβ alone.
Sample groups: NDV: DCs infected with NDV; IFNβ: DCs exposed to IFNβ
alone; AVDCs: DCs exposed to paracrine signaling from NDV infected cells in
a trans-well system; CTRL: naive unexposed and uninfected DCs.
(A) Principal component analysis of samples on all genes represented on the
microarray. First three principal components showing 41.9% (PC1), 14.1%
(PC2), and 9.94% (PC3) of the overall change in gene expression in the data
set. (B) Venn diagram comparing genes which differed (twofold, FDR
p<0.05) between each pair of conditions. (C) Genes which are differed
between AVDC vs. CTRL and AVDC vs. IFNβ and have a gene ontology
association with anti-viral immune processes.
twofold change threshold relative to control cells identified 7088
genes altered by NDV infection, 3600 genes altered by paracrine
signaling (AVDC), and 3336 genes changed by IFNβ alone.
The number of genes differentially expressed between each pair
of the four groups studied is indicated in Figure 1B. A compari-
son between cells exposed to paracrine signaling and IFNβ alone
showed 705 differentially expressed genes. From those 705 tran-
scripts, which showed a significant change between exposure to
paracrine signaling and single cytokine IFNβ treatment, 81 were
significantly altered by the paracrine signaling but did not show
significant induction by NDV infection or IFNβ treatment when
compared to control [Group (A) in Figure 1B], 191 genes were
significantly induced by paracrine signaling and NDV infection
but not IFNβ treatment when compared to control [Group (B) in
Figure 1B] and 111 genes were significantly induced by paracrine
signaling, NDV infection, and IFNβ treatment when compared to
control [Group (C) in Figure 1B]. Three genes were changed by
paracrine signaling and IFNβ treatment when compared to control
but still differed significantly when compared between exposure
to paracrine signaling and IFNβ treatment. Heat maps of all genes
in groups A, B, C, and D can be seen in the supplementary mate-
rial (Figure S2 in Supplementary Material). Fifty genes from the
list of 389 transcripts being significantly different when exposed
to paracrine signaling vs. IFNβ alone, as well as when exposed to
paracrine signaling and naive cells could be linked to anti-viral
immunity (Figure 1C). Among those, 50 genes were regulators
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of inflammation and immune response including VCAM-1 (17),
AQP9 (18), RIPK2 (19), IRAK2 (20), CCL3L1 (21); cytokines like
IL6, OSM (22); genes linked to anti-viral immunity CCL3L3 (23),
CSF1 (24), CD274 (25), CD40 (26), IL7R (27); immune cell acti-
vation CLEC5A (28), EDN (29), CST7 (30), and also a suppressor
of apoptosis PTGER4 (31).
BYSTANDER DCs ARE EXPOSED TO A COMPLEX CYTOKINE
ENVIRONMENT
To identify cytokines and chemokines induced during NDV infec-
tion, to which uninfected bystander DC cells are exposed, we
analyzed the 7088 transcripts induced by NDV. Seventy-eighty
transcripts could be associated to the gene ontology terms cytokine
activity or chemokine activity (Figure 2A). We further narrowed
this list by setting an expression threshold of 6.5 based on the inter-
section of the two populations of expressed and non-expressed
genes (Figure 2B) and identifying which cytokines/chemokines
could be associated with receptor genes also expressed in DCs.
This analysis linked CCL4 to CCR5 (32, 33), CCL3 to CCR5 (34),
CCL3 to CCR1 (35), CCL2 to CCR2 (36, 37), CCL7 to CCR5 (33),
CCL7 to CCR3 (38), CCL8 to CCR2 (39), CXCL10 to CCR3 (40),
CXCL9 to CCR3 (40), CXCL11 to CCR3 (40), CCL15 to CCR3
(41), CCL15 to CCR1 (41), CCL5 to CCR3 (36), CCL5 to CCR5
(42, 43), CXCL12 to CXCR4 (44), CXCL3 to CXCR2 (36), CXCL5
to CXCR2 (45), CXCL1 to CXCR2 (46), IL6 to IL6R (47), IL1a
to IL1R1 (48), IL1β to IL1R2 (49), IL1β to IL1R1 (50), TNF to
TNFRSF1B (51),TNF to FAS (52),TNF to TNFRSF1A (53), IL15 to
IL15RA (54), IL7 to IL7R (55), IL7 to IL2RG (56), IFNβ to IFNAR1
(57), IFNβ to IFNAR2 (58), IFNW1 to IFNAR1 (59), IFNA2 to
IFNAR (60), IFNE to IFNAR1 (61), TNFSF10 to TNFRS10B (62),
CCL19 to CCR7 (63), TNFSF15 to TNFRSF6B (64), IL28A to
IL10RB (65), IL29 to IL10RB (65), IL12A to IL12RB1 (66), IL12A
to IL12RB1 (67), and CSF1 to CSF1R (68) (Figure 2C).
The level of expression of cytokines and chemokines identi-
fied by this bioinformatics analysis was measured in an 18-h time
course experiment (1) in supernatant from DCs infected by NDV,
(2) in the supernatant associated with AVDCs in trans-well exper-
iments, and (3) in supernatant of cells exposed to IFNβ alone
by ELISA (Figure 3A) or in cellular mRNA by real-time PCR
(Figure 3B). Cytokines which did not exhibit detectable expression
by ELISA or PCR (not shown) were excluded for further screen-
ing. This led to the selection of the following 20 cytokines and
chemokines for further study that were induced in NDV infected
DCs: TNFα, CCL3, IL8, CXCL10, CCL5, IL6, IFNα CXCL12,
IFNALPHA16, IL12a, IL18, IL1RA, IL28, IL29, TNFSF15, TNFSF4,
TNFSF10, IL1α, IL1β, and IFNβ.
IDENTIFICATION OF INDIVIDUAL CYTOKINES CONTRIBUTING TO
COMBINATORIAL EFFECTS
We next studied the combinatorial effects of the 20 cytokines iden-
tified above on the induction of maturation marker expression
in naïve DCs. Because studying all combinations of 20 cytokines
was impractical, we identified combinatorial cytokine candidates
by comparing the effect of all 20 cytokines on naïve DCs to
the effects of all possible 19-cytokine combinations lacking one
of the cytokines. These experiments used the maximum con-
centration measured by ELISA or, for cytokines measured by
PCR, the concentration was estimated from transcript levels by
comparing the PCR and ELISA levels of IFNβ. Many cytokines
peaked at about 10 h during the 18 h time course. Therefore,
we expose DCs to the cytokine mixtures for 8 h to best approx-
imate the conditions of the paracrine signaling during viral
infection. In this experiment, we used cells from three different
donors for biological replicates, which resulted in a high variance
of marker expression between donors. To adjust for differences
between individuals, we normalized data to the overall median
values.
The absence of TNFα, IL18, IL28, and IFNalpha16 reduced the
expression of CD86, when compared to the exposure to all 20
cytokines (Figure 4). The absence of IFNa2, IL18, IL1α, TNFSF15,
IL1β, and IFNβ reduced the expression of HLA-DR (Figure 4). We
studied nine cytokines (IFNα, IFNALPHA16, IFNβ, IL1α, IL1β,
IL18, IL28, TNFα, TNFSF15) in similar leave one cytokine out
experiments as well as single cytokine exposure studies. These nine
cytokines gave the same responses as the original 20, indicating
that the 11 cytokines excluded from further study are not major
contributors to maturation marker induction during paracrine
signaling (Figure 5). The cytokine minus one studies with the
remaining nine cytokines suggested the importance of IFNβ, for
CD86 upregulation and IFNβ, IL28, and TNFSF15 for HLA-DR
upregulation. When DCs were exposed to individual cytokines,
IFNβ and IL1β induced CD86 and IFNβ and TNFα induced HLA-
DR. Therefore five cytokines (IFNβ, IL28, TNFSF15, TNFα, IL1β)
were selected for further study.
TNFα, IFNβ, AND IL1β INDUCE A PARACRINE ACTIVATED ANTI-VIRAL
STATE
We studied the effects of combinations of the five cytokines on
maturation marker expression, viral resistance, and phagocytic
activity. For the maturation marker expression studies, human
DCs were exposed to combinations of the five cytokines for 8 h
and the levels of CD86 and HLA-DR were measured by flow
cytometry. IFNb alone increases the expression of both mark-
ers. The additional increases observed with all combinations of
cytokines did not achieve statistical significance in comparison to
IFNb alone with tight control for family wise error. IL28 did not
cause any trend toward an increase in maturation marker expres-
sion (Figure 6A). To improve statistical power, we performed
maturation marker induction experiments using four cytokines
IFNβ, TNFSF15, TNFα, and IL1b. Here, the combinations of
IFNβ with either TNFα or IL1b showed a significantly higher
induction of CD86 when compared to the effects of IFNβ alone
(Figure 6B). The combination of IFNβ with IL1b showed a signif-
icantly higher HLA-DR induction when compared to IFNb alone
(Figure 6C).
As one of the most important features observed in paracrine
activated AVDCs is resistance to viral infection (6), we pretreated
DCs with combinations of the five cytokines for 8 h and sub-
sequently infected them with an RFP expressing NDV for 8 h.
Infectivity was measured by using flow cytometry to quantify RFP
expression. Because infectivity by RFP-NDV is so sensitive to IFNβ,
its concentration was reduced for this study. Still, due to the effect
of the RFP insertion which makes the virus less viable and more
susceptible to the effects of IFNβ, changes observed with cytokine
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FIGURE 2 | Candidate NDV induced cytokines in DCs for a paracrine
effect on DCs. (A) Cytokines and chemokines induced by NDV (twofold FDR
p<0.05) compared to naive DCs. (B) Expression level of all genes expressed
in naive DCs. A cutoff of expression above 6.5 was used to identify potentially
expressed cytokine and chemokine receptors. (C) Ingenuity analysis linking
induced cytokines/chemokines to receptor genes also expressed in DCs.
combinations were statistically not significant when compared to
single cytokine IFNβ exposure. The combination of IFNβ and IL1β
showed the largest reduction of infection (Figure 6D).
Another feature of AVDCs is the heightened phagocytic activity
(10). Therefore, we tested fluorescent bead phagocytosis following
exposure to combinations of IFNβ, TNFSF15, TNFα, and IL1β.
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FIGURE 3 |Time course of expression of cytokines/chemokines in
NDV infected DCs, AVDC, and IFNβ exposed DCs determined by
(A) multiplex ELISA or IFNβ ELISA or (B) real-time PCR over an 18 h
period. NDV (red line) indicates measurements from supernatants
(ELISA) or cells (PCR) which were infected with NDV at an MOI of 1.
AVDC (black line) indicates measurements from supernatants from
infected and co-cultured naïve DCs at a 1:1 ratio (ELISA) or naïve DCs
which were co-cultured with infected cells (PCR). IFNβ (blue line)
indicates measurements from supernatants (ELISA) or cells (PCR) from
naïve DCs exposed to IFNβ alone.
To improve statistical power and in view of the lack of effect
on maturation markers, IL28 was excluded from this study. Cells
were pretreated with cytokine combinations for 8 h, and then co-
cultured with fluorescent beads for 4 h. The number of beads in
each cell was then counted using imaging flow cytometry. The
highest rates of phagocytosis were seen with all four cytokines
exposed together and with exposure to IFNβ with either IL1β or
TNFSF15 (Figure 6E).
We also looked at the capacity of combinations of the five
cytokines to regulate 16 immune related genes that had been iden-
tified as preferentially induced by paracrine signaling in compari-
son with IFNβ exposure alone (see Figure 1C). Here, we exposed
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FIGURE 4 | Contribution of individual cytokines in 20 cytokine paracrine signal. Maturation marker expression of DCs after 8 h to exposure to all 20
cytokines (all) or the leave-one-out combinations of 19 cytokines. Note that a reduction in expression with a cytokine absent indicates that the cytokine may
contribute to induction.
FIGURE 5 | Contribution of individual cytokines in nine cytokine
paracrine signal. Maturation marker expression of DCs after 8 h to exposure
to all nine cytokines, all leave-one-out combination of eight cytokines and
each individual cytokine treatment (Single cytokine) (*p≤0.002 to cells
exposed to all nine cytokines in Cytokine-1 treatment and to untreated cells in
the single cytokine treatments).
DCs for 8 h to all possible combinations of IFNβ, IL28, TNFSF15,
TNFα, IL1β, mRNA, and performed qPCR. Gene expression is
plotted on a heatmap (Figure 7). The genes assayed were VCAM-1,
AQP9, RIPK2, IRAK2, CCL3L1, IL6, OSM, CCL3L3, CSF1, CD274,
CD40, IL7R, CLEC5A, EDN, CST7, and PTGER4). Nine of these
genes showed the highest induction when treated with the triple
combination of IFNβ,TNFα, and IL1β (Figure 7). The genes show-
ing combinatorial cytokine preferences are associated with anti-
viral immunity (CCL3L3, CSF1, IL7R), regulation of inflammation
(AQP9, IRAK2, RIPK2), and immune cell activation (CST7, EDN,
cytokine OSM ). The induction of IL6 was also high with the triple
cytokine treatment. Overall, these experiments demonstrate that
IFNβ, TNFα, and IL1β acting together are the principal drivers of
the paracrine induced anti-viral state in DCs.
We next performed concentration response studies to deter-
mine if the combinatorial effects of the cytokines were syn-
ergistic. At lower concentrations, all three cytokines together
produced the highest levels of both CD86 expression although
at higher concentrations, equivalent levels could be achieved
with the combination of TNFα and IFNβ alone (Figure 8).
For HLA-DR expression, the combination of all three cytokines
at lower concentrations produced the highest levels, although
at higher concentrations TNFα and IL1β induced similar lev-
els. For both maturation markers, the effects of combinatorial
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FIGURE 6 | Effects of combinatorial cytokine treatment. (A) Maturation
marker expression after exposure to combinations of IFNβ, IL28, TNFSF15,
TNFα and IL1β, measured by flow cytometry (*p≤0.05 compared to
untreated cells). (B) CD86 expression after exposure to combinations of
IFNβ, TNFSF15, TNFα and IL1β, measured by flow cytometry (*p≤0.05
compared to cells treated with IFNβ alone). (C) HLA-DR expression after
exposure to combinations of IFNβ, TNFSF15, TNFα and IL1β, measured by
flow cytometry (*p≤0.05 compared to cells treated with IFNβ alone).
(D) Infectivity of NDV after cytokine combination pretreatment for 8 h in
DCs measured by RFP expression. (E) Phagocytosis assay measured by
bead uptake by imaging flow cytometry (*p≤0.05 compared to
untreated cells).
exposure dramatically exceeded the effects of any individual
cytokine. Statistical values for pairwise comparisons within each
dilution step are shown in Tables S1 and S2 in Supplemen-
tary Material. We also investigated the effect of combinations
of various combinations of the two cytokines IFNβ and TNFα,
which showed a synergistic induction with CD86 (Figure
S3 in Supplementary Material). These results support the
view that the effects of combinatorial exposure produce a
qualitatively different cellular effect than do the individual
cytokines.
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FIGURE 7 | Gene expression of immune relevant genes after combinatorial IFNβ, IL28,TNFSF15,TNFα, and IL1β treatment. Heat map is normalized to the
lowest (blue) and highest (red) expression level for each individual gene (*p≤0.05 compared to cells exposed to the triple combination of TNFα, IFNβ, and IL1b).
FIGURE 8 | Maturation marker expression by combinations of IFNβ,TNFα, and IL1β. DCs were exposed to combinations of three cytokines at a range of
concentrations relative to that found in supernatants of NDV infected DCs.
COMBINATORIAL EFFECTS OF TNFα, IL1β, AND IFNβ ON PATHOGENIC
VIRUSES
The studies described above rely on NDV, which is not pathogenic
in humans and does not express immune antagonists having activ-
ity in human cells. We were interested in studying the effects of
combination cytokine exposure on a human pathogen and stud-
ied the recent pandemic Influenza A virus Cal/09. We pretreated
DCs with all combinations of IFNβ, TNFα, and IL1β for 8 h and
subsequently infected them with influenza A/California/7/2009
and measured infectivity, maturation marker induction as well
as induction of apoptosis. The triple combination of all three
cytokines as well as the dual cytokine mixture of IL1β and
IFNβ significantly increased the suppression of infectivity when
compared to IFNβ pretreatment alone (Figure 9A). The triple
combination also caused the highest induction of CD86, HLA-
ABC, and HLA-DR in virus NP-expressing cells (Figures 9B–D).
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Apoptosis was assayed in the same samples using imaging flow
cytometry to measure nuclear fragmentation (Figures 9F,G).
Interestingly, pretreatment with single cytokines did not reduce
influenza-induced apoptosis, whereas the triple combination as
well as the dual cytokine combinations with IFNβ could reduce cell
death (Figure 9E). These data suggests that the triple combination
of cytokines improves DC survival, resistance to infectivity, and
increases costimulatory marker expression for T-cell activation.
COMBINATORIAL EFFECT OF TNFα, IL1β, AND IFNβ ON INDUCTION OF
VIRUS SPECIFIC T-CELL RESPONSE
In order to see if the induction of the costimulatory mark-
ers by the triple combination of IFNβ, TNFα, and IL1β has an
effect on T-cell activation, we studied the induction of measles
specific T-cell proliferation after co-culture with cytokine pre-
treated and measles primed T-cells. We exposed the CD14 depleted
PBMCs from the same donors which were used for DC genera-
tion to measles vaccine and harvested T-cell 5 days later. Those
T-cells were co-cultured for 3 days with measles primed DCs
exposed to combinations of IFNβ, TNFα and IL1β. Prolifera-
tion was measured by the dilution of the membrane bound dye
CFSE by flow cytometry. The triple combination of IFNβ, TNFα,
and IL1β significantly increased cell proliferation compared to
non-pretreated DCs (Figure 10). These results indicate that the
costimulatory marker upregulation also affects activation of the
adaptive immune system.
FIGURE 9 | Effects of combinatorial of IFNβ,TNFα, and IL1β treatment
on DCs infected with the pandemic influenza A Cal/09 strain.
(A) Infectivity assayed by NP expression (*p≤0.05 compared to cells
exposed to IFNβ). (B) Expression of the maturation marker CD86.
(C) Expression of the maturation marker HLA-ABC. (D) Expression of the
maturation marker HLA-DR (*p≤0.05 compared to cells exposed to the
triple combination of TNFα, IFNβ, and IL1b). (E) Apoptosis assayed by
assessing nuclear fragmentation and cell granularity by imaging flow
cytometry (*p≤0.05 compared to untreated cells). (F) Sample images of
non-apoptotic cells. (G) Sample images of apoptotic cells.
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FIGURE 10 | Antigen specific proliferation ofT-cells exposed to cytokine
pretreated DCs. Measles antilogous specific T-cells were co-cultured with
cytokine pretreated DCs which were also pulsed with measles vaccine.
Proliferation was measured by the dilution of CFSE.
COMBINATORIAL EFFECT OF TNFα, IL1β, AND IFNβ ON INFLUENZA
MORBIDITY IN VIVO
We next studied the effects of IFNβ, TNFα, and IL1β on influenza
virus pathogenicity in vivo using a well-characterized aerosolized-
virus mouse infection model (69). Cytokines were injected
intraperitoneally both 3 h before and after inhalation infection
with PR8 virus. While the differences were modest, the triple
combination was found to improve survival times significantly
compared to control (p: 0.0456) following PR8 infection in mice
(Figure 11).
DISCUSSION
In this study, we show that IFNβ, TNFα, and IL1β are secreted by
virus-infected DCs and act combinatorially to alter the anti-viral
response state of uninfected DCs. This combination is responsible
for maturation marker upregulation in naive as well as in infected
cells, reduction of virus induced apoptosis, heightened phagocytic
activity, specific autologous T-cell activation,and resistance to viral
infection in vitro as well as in in vivo.
The importance of cellular micro-environments in dictating
immune cell responses is supported by the report that the inflam-
matory state of macrophages can be reprogramed by exposure to
an anti- or pro-inflammatory stimuli (70). Another report has
suggested that the initial exposure to a cytokine signal determines
and fixes the final state of the macrophage (71). These reports, as
well as the finding that the combination of IL-4, IL-10, and TGFb
skew the development of myeloid cells into M2 macrophages, sup-
port the importance of combinatorial cytokine signals in immune
regulation (72). DCs themselves are differentiated into different
lineages by exposure to different cytokines including GMCSF and
Flt3 (73).
FIGURE 11 | Effects of IFNβ,TNFα, and IL1β combinations on mortality
with PR8 virus in vivo. Mice received cytokine injection i.p. 6 h before and
6 h after infection with PR8 virus.
Since the discovery of type I interferon, paracrine cytokine
signaling has been recognized as a crucial component in orches-
trating the immune responses to virus infection. Recent studies
have begun to reveal the importance of combinatorial extracellular
stimuli in directing the responses of immune cells. For example,
when DCs are exposed to lipopolysaccharide in the context of
apoptotic cells, they induce TH17 cells, a response that is not
achieved by either stimulus alone (74). Retinoic acid acts alone
on T-cells to induce Treg cells. However, retinoic acid combined
with IL-15 causes DCs to skew the T-cell polarization toward TH17
cells (6). TLR7/8 ligand combined with either TLR3 or TLR4 lig-
ands synergistically increases IFNβ and IFNλ1 expression in DCs
(75). SCF and IL-2 have a synergistic effect on the proliferation
NK cells (7). TNFα and IFNγ act together on smooth airway cells
to enhance CXCL-10 expression (8). IL17 together with TNFα
or IL1β induces MCP-1 and MIP-2 in murine mesangial cells
(9). These combinatorial effects are likely to prove clinically rel-
evant, for example, by contributing to individual differences in
the response to cytokine treatment (76). While beyond the scope
of the present investigation, the role of relative timing of com-
binatorial cytokine signals is another important area for further
study. We have also not addressed the potential combinatorial role
of alarmins, which can work in concert with cytokines to induce
different cell states (77).
To our knowledge, this is the first report of IFNβ, TNFα, and
IL1β working in concert to alter the response state of any immune
cell. Previous studies have implicated pairs of this triad in influ-
encing immune responses. The combination of IL-1β and IFNβ
has been reported to promote immune control of West Nile virus
infection in the CNS (78). TNFα and IFNβ have also been found
to affect macrophages and fibroblasts in reducing the infectivity
of poxviruses (79, 80).
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Several of the transcripts that are preferentially induced in DCs
by the exposure to all three cytokines have been found to serve
important roles in inflammation and immunity: CCL3L3 sup-
presses HIV proliferation (23); AQP9 is a marker for inflammation
(81); CSF1 is a biomarker for respiratory syncytial virus infec-
tion (24); RIPK2 knockout in mice causes hyper-susceptibility to
infection with influenza A virus (82); EDN possesses anti-viral
activity against single stranded RNA viruses like respiratory syn-
cytial virus, Hepatitis and HIV (83); IL7R expression inversely
correlates with FoxP3 and suppressive function of human CD4+
T reg cells (84); OSM is a pro-inflammatory cytokine (22); and
IRAK2 is needed to sustain cytokine production during prolonged
activation of the TLR signaling pathway (85). When maturation
marker induction was studied by cytokine induction alone, we
found that CD86 is most strongly driven by IFNβ with syner-
gistic effects of TNFα or IL1β. HLA-DR was little changed by
individual cytokines but was strongly induced by TNFα and IL1β
together. The gene VCAM-1 was most induced by the TNFα
and IL1β together and PTGER4 was most induced by IFNβ
and TNFα. While the overall DC cell state observed requires all
three cytokines, the differences in the cytokines most impor-
tant for various components of these DC responses provides
the basis for future studies to dissect the underlying signaling
and transcriptional mechanisms involved in these combinatorial
effects.
Surprisingly, the triple combination of IFNβ, TNFα, and IL1β
reduced influenza-induced cell death in infected DCs. This is inter-
esting as IFNβ is known to be an inducer of apoptosis in DCs (86),
and indicates how the effects of one cytokine may be very different
depending on which other cytokines are stimulating a cell. Matu-
ration marker induction as well as cell survival are important for
the activation of the adaptive immune system. The observation of
a heightened proliferation of virus specific T-cells when exposed
to DCs pretreated with the triple combination supports this view.
The modestly increased survival of mice to PR8 infection when
treated with the three cytokines suggests the combinatorial coding
of cell responses has significance in vivo.
The large number of cytokines secreted by infected DCs is
remarkable. We identify combinatorial effects involving only three
of these secreted factors on DCs. It is probable that combi-
natorial signaling of different cytokine mixtures influences the
activation state of other immune cells and that other immune
cells also serve as the source of complex cytokine signals. The
specific activation state of any immune cell can depend on
both the cytokine mixture present and their concentration (see
Figure 8). Thus the immune system can potentially generate
many distinct micro-environments that shape the local activa-
tion state of various immune cells. This provides the poten-
tial for a dynamic and spatially distributed complexity of the
set point of the immune system that could be crucial in orga-
nizing the local and system responses to infection, neoplasia,
and injury. Unraveling this combinatorial code may have ben-
efits in guiding combination immunotherapy for autoimmune
diseases, for chronic infections and for other immune system
influenced diseases as well as for personalizing interventions
in relationship to individual variation in background cytokine
expression.
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